Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al

Name: Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al
Published: 2023-12-18T00:00:00+08:00

NIAID Data Ecosystem2026-05-01 收录

dupilumab安全性评估

特应性皮炎不良事件

数据链接：

https://data.mendeley.com/datasets/d23bwhdnkh 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table I: Adverse events during the follow-up period in patients treated with dupilumab.

创建时间：

2023-12-18

Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al

资源简介：

相关数据集